Both in Pharmaceuticals
Perspective Therapeutics vs NeOnc Technologies Holdings
Over the past year CATX returned −62.7% and NTHI returned −69.8%; their daily moves had a correlation of -0.00.
CATX −62.7% NTHI −69.8%Growth of $1, one year, split-adjusted
| Metric | CATX | NTHI |
|---|---|---|
| Price | $0.8702 | $3.17 |
| Market cap | $99.3M | $91.3M |
| Today | −1.11% | +3.26% |
| 1 month | −63.1% | +6.0% |
| 6 months | −77.2% | −40.3% |
| Year to date | −68.4% | −61.7% |
| 1 year | −66.5% | −68.9% |
| Revenue growth (YoY) | −72.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −33069.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 242.9× | — |
| Net cash | $235.3M | $2.0M |
| Dividend yield | — | — |
| Volatility (60d) | 117.1% | 132.7% |
| Short % of float | 17.1% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).